Related Experiment Video
Updated: Mar 13, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
The ABCs of managing systolic heart failure: Past, present, and future
Ike Stanley Okwuosa1, Oluseyi Princewill1, Chiemeke Nwabueze2
1Division of Cardiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
Insights
Current heart failure management is complex. This review provides an evidence-based approach to updated heart failure (HF) treatments, incorporating new drugs and devices since the 2013 guidelines.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Heart failure (HF) management is intricate and continually advancing.
- The last comprehensive evidence-based guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) were published in 2013.
- Significant advancements in pharmacotherapy and device-based therapies have emerged since 2013.
Purpose of the Study:
- To present a contemporary, evidence-based strategy for managing heart failure.
- To synthesize recent developments in HF treatment modalities.
- To guide clinicians in applying updated evidence to patient care.
Main Methods:
- Systematic review of recent clinical trials and guideline updates.
- Analysis of pharmacological interventions, including newly approved agents.
- Evaluation of novel device therapies for heart failure.
Main Results:
- Updated recommendations for guideline-directed medical therapy (GDMT) in HF.
- Integration of new drug classes (e.g., SGLT2 inhibitors, ARNIs) into HF management algorithms.
- Consideration of advanced device therapies (e.g., CRT, ICDs) based on latest evidence.
Conclusions:
- Current heart failure management requires incorporating recent evidence on novel therapies.
- A multidisciplinary, evidence-based approach is crucial for optimizing outcomes in heart failure patients.
- Adherence to updated guidelines ensures the best possible patient care and prognosis.
Abstract:
Heart failure management is complex and constantly evolving. The American College of Cardiology and the American Heart Association (ACC/AHA) last issued evidence-based guidelines in 2013, and since then, new drugs and devices have been developed. This review presents an evidence-based approach to current heart failure management.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Mitral Regurgitation IV: Nursing Management
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care

